Your browser doesn't support javascript.
loading
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.
Averbuch, Itamar; Salman, Saeed; Shtamper, Noa; Doweck, Ilana; Popovtzer, Aron; Markel, Gal; Hendler, Daniel; Finkel, Inbar; Moore, Assaf; Fenig, Eyal; Taha, Tarek; Mhameed, Kamel; Kurman, Noga; Billan, Salem.
Afiliación
  • Averbuch I; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Salman S; The Joseph Fishman Oncology Center, Rambam Health Care Campus, Haifa, Affiliated to the Rappaport Faculty of Medicine, Israel Institute of Technology-Technion, Haifa, Israel.
  • Shtamper N; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Doweck I; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Popovtzer A; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
  • Markel G; Department of Otolaryngology-Head and Neck Surgery, Carmel Medical Center, Haifa, Affiliated to the Rappaport Faculty of Medicine, Israel Institute of Technology-Technion, Haifa, Israel.
  • Hendler D; Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem, Affiliated with the Hebrew University of Jerusalem, Jerusalem, Israel.
  • Finkel I; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Moore A; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Fenig E; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Taha T; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Mhameed K; Davidoff Cancer Center, Rabin Medical Center - Beilinson Hospital, Petach Tikva Affiliated to Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kurman N; Oncology Institute, Baruch Padeh Medical Center, Poriya, Affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Poriya, Israel.
  • Billan S; The Joseph Fishman Oncology Center, Rambam Health Care Campus, Haifa, Affiliated to the Rappaport Faculty of Medicine, Israel Institute of Technology-Technion, Haifa, Israel.
Front Oncol ; 13: 1117804, 2023.
Article en En | MEDLINE | ID: mdl-36793605
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza